
Recro Reports Inducement Grants for New Staff
MALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH) this week announced the expansion of its team through the addition of new employees primarily in the areas of analytical development, business …
Read MoreChester County News and Community Website
Recro (Nasdaq: REPH), headquartered in Malvern, PA, is a contract development and manufacturing organization, or CDMO, with integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and development stage oral solid dose drug products. For more information see www.recrocdmo.com.
MALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH) this week announced the expansion of its team through the addition of new employees primarily in the areas of analytical development, business …
Read MoreMALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH) announced significant recent progress in strengthening the company’s business development team to support its strategic objective of expanding and diversifying its customer …
Read MoreMALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH) announced that its chief executive officer, David Enloe, will deliver a corporate presentation as part of the H.C. Wainwright Global Life Science …
Read MoreMALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH), a dedicated contract development and manufacturing organization (CDMO), solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, …
Read MoreMALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug …
Read MoreMALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug …
Read MoreMALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH), a dedicated contract development and manufacturing organization (CDMO) solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, …
Read MoreMALVERN, PA — Recro (Nasdaq: REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and …
Read MoreMALVERN, PA — Recro (Nasdaq: REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and …
Read MoreMALVERN, PA — Recro (Nasdaq: REPH) has reported financial results for the three and nine months ended September 30, 2020.
Read More